Consideration of Splenectomy in Unstable Hemoglobinopathy: A Case Report of Hb Hammersmith (HBB: c.128T>C)

References

• Modell B. World Health Organization. Guidelines for the control of haemoglobin disorders. Report of the VIth Annual Meeting of the WHO Working Group on Haemoglobinopathies, Cagliari, Sardinia, 8–9 April, 1989. Geneva, World Health Organization, 1989. (unpublished document WHO/HDP/WG/HA/89.2). Available from: https://apps.who.int/iris/handle/10665/66665
   Google Scholar
• Kaushansky K, Lichtman MA, Prchal JT, editors, et al. Williams manual of hematology. 9th ed. New York (NY): McGraw Hill Education; 2017. [Accessed May 10 2021]. Available at: https://hemonc.mhmedical.com/content.aspx?bookid=1889&sectionid=137388048
   Google Scholar
• Globin Gene Server [Internet]. [Accessed October 7 2021]. Available at: https://globin.bx.psu.edu/
   Google Scholar
• Grimes AJ, Meisler A, Dacie JV. Congenital Heinz-body anaemia: further evidence on the cause of Heinz-body production in red cells. Br J Haematol. 1964;10:281–290.
   PubMed Web of Science ®Google Scholar
• Dacie JV, Shinton NK, Gaffney PJ., Jr, et al. Haemoglobin Hammersmith (beta-42 (CDI) Phe replaced by ser). Nature. 1967;216(5116):663–665.
   PubMed Web of Science ®Google Scholar
• Park S, Kang HJ, Cho SI, et al. A case report of a male patient with Hb Hammersmith [β42(CD1)Phe→Ser, TTT>TCT]. Hemoglobin. 2012;36(2):161–165.
   PubMed Web of Science ®Google Scholar
• Pincez T, Guitton C, Gauthier F, et al. Long-term follow-up of subtotal splenectomy for hereditary spherocytosis: a single-center study. Blood. 2016;127(12):1616–1618.
   PubMedGoogle Scholar
• Englum BR, Rothman J, Leonard S, et al. Splenectomy in congenital hemolytic anemia consortium. Hematologic outcomes after total splenectomy and partial splenectomy for congenital hemolytic anemia. J Pediatr Surg. 2016;51(1):122–127.
   PubMedGoogle Scholar
• Ammar SA, Elsayh KI, Zahran AM, et al. Splenectomy for patients with β-thalassemia major: long-term outcomes. Egypt J Surg. 2014;33(4):232–236.
   Google Scholar
• Iolascon A, Andolfo I, Barcellini W, et al. Recommendations regarding splenectomy in hereditary hemolytic anemias. Haematologica. 2017;102(8):1304–1313.
   PubMed Web of Science ®Google Scholar
• Lang SA, Chang PC, Laxdal VA, et al. Haemoglobin Hammersmith precludes monitoring with conventional pulse oximetry. Can J Anaesth. 1994;41(10):965–968.
   PubMedGoogle Scholar
• Shinton NK, Williams HP, Thursby-Pelham DC. Congenital Heinz-body haemolytic anaemia due to haemoglobin Hammersmith. Postgrad Med J. 1969;45(527):629–632.
   PubMedGoogle Scholar
• Akiyama M, Murayama S, Yokoi K, et al. Hemoglobin Hammersmith [beta 42(CD1) Phe→Ser] causing severe hemolytic anemia in a Japanese girl. Pediatr Blood Cancer. 2006;47(6):839–841.
   PubMedGoogle Scholar
• Eandi Eberle SJ, Noguera N, Calvo K, et al. Severe hemolytic anemia due to hemoglobin Hammersmith. Arch Argent Pediatr. 2009;107(4):347–349.
   PubMedGoogle Scholar
• Cappellini MD, Cohen A, Eleftheriou A, et al. Guidelines for the clinical management of thalassaemia. 2nd ed. Nicosia (Cyprus): Thalassaemia International Federation; 2008.
   Google Scholar
• King H, Shumacker HB, Jr. Splenic studies. I. Susceptibility to infection after splenectomy performed in infancy. Ann Surg. 1952;136(2):239–242.
   PubMed Web of Science ®Google Scholar
• Jugenburg M, Haddock G, Freedman MH, et al. The morbidity and mortality of pediatric splenectomy: does prophylaxis make a difference? J Pediatr Surg. 1999;34(7):1064–1067.
   PubMedGoogle Scholar
• Alkhatrawi T, Elsherbini R, Turkistani W. Laparoscopic splenectomy in children with sickle cell disease younger than 5 years old. Ann Pediatr Surg. 2020;16(1). DOI:10.1186/s43159-020-00047-7. Available at: https://aops.springeropen.com.
   Google Scholar
• Dianzani I, Ramus S, Cotton RG, et al. A spontaneous mutation causing unstable Hb Hammersmith: detection of the β 42 TTT—TCT change by CCM and direct sequencing. Br J Haematol. 1991;79(1):127–129.
   PubMedGoogle Scholar
• Li R, Wang T, Xie XM, et al. Case report: prenatal diagnosis of Hb Hammersmith [β42(CD1)Phe→Ser; HBB: c.128T>C] in a family with an adult male patient. Hemoglobin. 2014;38(2):142–145.
   PubMed Web of Science ®Google Scholar
• Wajcman H, Leroux A, Labie D. Functional properties of hemoglobin Hammersmith. Biochimie. 1973;55(2):119–126.
   PubMedGoogle Scholar
• Ohba Y, Miyaji T, Matsuoka M, et al. Hemoglobin Chiba: Hb Hammersmith in a Japanese girl. Nihon Ketsueki Gakkai Zasshi. 1975;38(1):53–58.
   PubMedGoogle Scholar
• Rahbar S, Feagler RJ, Beutler E. Hemoglobin Hammersmith (beta 42 (CD1) Phe replaced by Ser) associated with severe hemolytic anemia. Hemoglobin. 1981;5(1):97–105.
   PubMed Web of Science ®Google Scholar
• Schroeder WA, Shelton JB, Shelton JR, et al. Identification of eleven human hemoglobin variants by high-performance liquid chromatography: additional data on functional properties and clinical expression. Biochem Genet. 1982;20(1–2):133–152.
   PubMedGoogle Scholar
• Rahbar S, Bennetts GA, Ettinger LJ. Hemoglobin Hammersmith as the cause of severe hemolytic anemia in a Chinese girl. Am J Pediatr Hematol Oncol. 1986;8(1):13–17.
   PubMedGoogle Scholar
• Cunningham TA, Baker F, Kobrinsky NL, et al. The unstable Hb Hammersmith or α2β2(42)(CD1)Phe—Ser observed in an Indian child; identification by HPLC and by sequence analysis of amplified DNA. Hemoglobin. 1992;16(1–2):19–25.
   PubMed Web of Science ®Google Scholar
• Tuohy AM, McKie VC, Sabio H, et al. Hb Hammersmith [beta 42(CD1) Phe→Ser]: occurrence as a de novo mutation in black monozygotic twins with multiple congenital anomalies. J Pediatr Hematol Oncol. 1998;20(6):563–566.
   PubMed Web of Science ®Google Scholar
• Hung CC, Chien SC, Su YN, et al. Denaturing high-performance liquid chromatography: an efficient screening approach in the genetic diagnosis of hemoglobin Hammersmith. Biomed Eng Appl Basis Commun. 2006;18(06):343–347.
   Google Scholar
• Sonati MF, Kimura EM, Abreu CF, et al. Hemoglobin Hammersmith [beta42 (CD1) Phe→Ser] in a Brazilian girl with congenital Heinz body hemolytic anemia. Pediatr Blood Cancer. 2006;47(6):855–856.
   PubMed Web of Science ®Google Scholar